Evidence map›Paper›PMID 38619879›Full record

ArticleEnvironmental health perspectives2024

Multiomics Analysis of PCB126's Effect on a Mouse Chronic-Binge Alcohol Feeding Model.

Tyler C Gripshover, Banrida Wahlang, Kimberly Z Head, Jianzhu Luo, Oluwanifemi E Bolatimi, Melissa L Smith, Eric C Rouchka, Julia H Chariker, Jason Xu, Lu Cai and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Tyler C GripshoverDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Banrida WahlangDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Kimberly Z HeadDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Jianzhu LuoDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA.
Oluwanifemi E BolatimiDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Melissa L SmithThe Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA.
Eric C RouchkaDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Julia H CharikerKentucky IDeA Network of Biomedical Research Excellence (KY INBRE) Bioinformatics Core, University of Louisville, Louisville, Kentucky, USA.ORCID 0000-0001-6805-7220
Jason XuDepartment of Pediatrics, Pediatric Research Institute, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Lu CaiDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Timothy D CumminsDivision of Nephrology and Hypertension, Department of Medicine and Clinical Proteomics Center, University of Louisville, Louisville, Kentucky, USA.
Michael L MerchantDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Hao ZhengThe Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA.
Maiying KongThe Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA.
Matthew C CaveDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
University of Louisville · US

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Bruce A Mattingly · 2012 to 2026
$60.1M
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HOOD, JOSHUA L. · 2016 to 2025
$24.1M
Superfund Training CoreP42ES023716 · NIEHS · UNIVERSITY OF LOUISVILLE · PI HEIN, DAVID W · 2017 to 2025
$18.1M
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ InjuryP50AA024337 · NIAAA · UNIVERSITY OF LOUISVILLE · PI CRAIG J. MCCLAIN · 2016 to 2026
$17.9M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Environmental Liver DiseaseR35ES028373 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2017 to 2024
$4.0M
Biomarkers of Alcoholic HepatitisR01AA028436 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ARTEEL, GAVIN E, BENOS, PANAGIOTIS V · 2020 to 2024
$3.0M
Exposome and Precision Medicine in NAFLDR01ES032189 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2020 to 2022
$1.9M
m6A Epitranscriptomics in Toxicant Associated SteatohepatitisR21ES031510 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C, KLINGE, CAROLYN M. · 2020 to 2021
$546k
Evaluating mechanisms of sex differences in environmentally-induced metabolic diseasesK01ES033289 · NIEHS · UNIVERSITY OF LOUISVILLE · PI WAHLANG, BANRIDA · 2022 to 2024
$448k
NIAAA NIH HHS P50 AA024337NIAAA NIH HHS R01 AA028436NIEHS NIH HHS K01 ES033289NIEHS NIH HHS P30 ES030283NIEHS NIH HHS P42 ES023716NIEHS NIH HHS R01 ES032189NIEHS NIH HHS R21 ES031510NIEHS NIH HHS R35 ES028373NIEHS NIH HHS T32 ES011564NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20 GM113226
6 · The paper itself

Abstract

backgroundEnvironmental pollutants, including polychlorinated biphenyls (PCBs) have been implicated in the pathogenesis of liver disease. Our group recently demonstrated that PCB126 promoted steatosis, hepatomegaly, and modulated intermediary metabolism in a rodent model of alcohol-associated liver disease (ALD).

objectiveTo better understand how PCB126 promoted ALD in our previous model, the current study adopts multiple omics approaches to elucidate potential mechanistic hypotheses.

methodsBriefly, male C57BL/6J mice were exposed to

resultsPrincipal component analysis showed that PCB126 uniquely modified the transcriptome in EtOH-fed mice. EtOH feeding alone resulted in DISCUSSION: Previous work has demonstrated that PCB126 is a modifying factor in metabolic dysfunction-associated steatotic liver disease (MASLD), and our current work suggests that pollutants also modify ALD. PCB126 may, in part, be contributing to the malnutrition aspect of ALD, where metal deficiency is known to contribute and worsen prognosis. https://doi.org/10.1289/EHP14132.

Indexed as

Environmental PollutantsFatty LiverLiver Diseases, AlcoholicPolychlorinated BiphenylsAnimalsEthanolLiverMaleMiceMice, Inbred C57BLMultiomicsTyrosineZinc3,4,5,3',4'-pentachlorobiphenylEnvironmental PollutantsEthanolPolychlorinated BiphenylsTyrosineZinc

Identifiers

PMID38619879
PMCPMC11018247
OpenAlexW4394824302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.